Impax Asset Management Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-331,875
Closed -$34.3M 418
2021
Q4
$34.3M Buy
331,875
+83,371
+34% +$9.65M 0.13% 103
2021
Q3
$31.1M Hold
248,504
0.13% 103
2021
Q2
$30.8M Buy
248,504
+34,300
+16% +$4.31M 0.14% 100
2021
Q1
$25.3M Hold
214,204
0.13% 96
2020
Q4
$25.1M Sell
214,204
-37,007
-15% -$4.07M 0.16% 86
2020
Q3
$26.1M Buy
251,211
+39,579
+19% +$3.97M 0.23% 74
2020
Q2
$19.4M Buy
211,632
+949
+0.5% +$91K 0.2% 82
2020
Q1
$19M Buy
210,683
+73,898
+54% +$7.86M 0.25% 79
2019
Q4
$15.5M Buy
136,785
+110,196
+414% +$12.1M 0.17% 95
2019
Q3
$2.89M Buy
26,589
+2,646
+11% +$276K 0.04% 180
2019
Q2
$2.33M Buy
23,943
+2,440
+11% +$223K 0.03% 179
2019
Q1
$1.96M Buy
21,503
+3,079
+17% +$276K 0.03% 208
2018
Q4
$1.68M Buy
18,424
+578
+3% +$54K 0.03% 192
2018
Q3
$1.76M Buy
+17,846
New +$1.65M 0.03% 197

Other funds holding MDT

Impax Asset Management Group's MDT Position: Q1 2022 in Review

Impax Asset Management Group sold out of Medtronic (MDT) in Q1 2022, closing a stake of 331,875 shares — an estimated $34.3M sold.

Impax Asset Management Group first reported a position in MDT in Q3 2018 and held it in 14 quarters. The position peaked at $34.3M in Q4 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Impax Asset Management Group reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Impax Asset Management Group sold 331,875 Medtronic shares in Q1 2022, an estimated $34.3M.
  • Impax Asset Management Group first reported a position in Medtronic in Q3 2018 and held it in 14 quarters.
  • Impax Asset Management Group's Medtronic position peaked at $34.3M in Q4 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Impax Asset Management Group's 13F filing for Q1 2022, filed 16 May 2022.